|
CollabRx Acquisition (Details) (USD $)
|
0 Months Ended | 3 Months Ended | 9 Months Ended |
|---|---|---|---|
|
Jul. 12, 2012
|
Dec. 31, 2013
|
Dec. 31, 2013
ClinicalandScientificAdvisor
|
|
| CollabRx Acquisition [Abstract] | |||
| Business acquisition effective date | Jul. 12, 2012 | Jul. 12, 2012 | |
| Acquisition agreement date | Jun. 29, 2012 | ||
| Assets acquired [Abstract] | |||
| Number of clinical and scientific advisors | 75 | ||
| "Big data" opportunity value | $ 300,000,000,000 | $ 300,000,000,000 | |
| Tax benefit recognized | $ 20,000 | $ 61,000 |
| X | ||||||||||
|
- Definition
Refers to value of the expert systems that provides clinically relevant interpretive knowledge. No definition available.
|
| X | ||||||||||
|
- Definition
Refers to number of clinical and scientific advisors available at leading academic institutions. No definition available.
|
| X | ||||||||||
|
- Definition
Date when the business acquisition agreement was executed, in CCYY-MM-DD format. No definition available.
|
| X | ||||||||||
|
- Definition
Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|